Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2841
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)